ELAN · Insider Trading
Elanco Animal Health Incorporated Common Stock
Every open-market purchase and sale reported by ELAN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-03 | Rajeev A. Modi | SEE REMARKS | A | +64 deriv. | — |
| 2026-11-03 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +122 deriv. | — |
| 2026-11-03 | Robert M VanHimbergen | EVP and CFO | A | +8 deriv. | — |
| 2026-10-20 | Rajeev A. Modi | SEE REMARKS | A | +62 deriv. | — |
| 2026-10-20 | Robert M VanHimbergen | EVP and CFO | A | +8 deriv. | — |
| 2026-10-20 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +120 deriv. | — |
| 2026-10-19 | Timothy J Bettington | SEE REMARKS | Sell | −4,350 | −$100.05K |
| 2026-10-06 | Robert M VanHimbergen | EVP and CFO | A | +8 deriv. | — |
| 2026-10-06 | Rajeev A. Modi | SEE REMARKS | A | +66 deriv. | — |
| 2026-10-06 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +127 deriv. | — |
| 2026-10-01 | Kapila K Anand | Director | A | +642 deriv. | — |
| 2026-09-22 | Robert M VanHimbergen | EVP and CFO | A | +8 deriv. | — |
| 2026-09-22 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +126 deriv. | — |
| 2026-09-22 | Rajeev A. Modi | SEE REMARKS | A | +65 deriv. | — |
| 2026-09-09 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +115 deriv. | — |
| 2026-09-09 | Rajeev A. Modi | SEE REMARKS | A | +60 deriv. | — |
| 2026-09-09 | Robert M VanHimbergen | EVP and CFO | A | +8 deriv. | — |
| 2026-08-25 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +117 deriv. | — |
| 2026-08-25 | Rajeev A. Modi | SEE REMARKS | A | +61 deriv. | — |
| 2026-08-25 | Robert M VanHimbergen | EVP and CFO | A | +8 deriv. | — |
| 2026-08-21 | Lawrence Erik Kurzius | Director | Buy | +40,000 | +$935.92K |
| 2026-08-18 | Shiv O'Neill | GC AND CORP SEC | Buy | +3,998 | +$94.27K |
| 2026-08-13 | Michael J Harrington | Director | Buy | +5,000 | +$109.10K |
| 2026-08-10 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +127 deriv. | — |
| 2026-08-10 | Paul Herendeen | Director | Buy | +10,000 | +$236.85K |
| 2026-08-10 | Robert M VanHimbergen | EVP and CFO | Buy | +4,200 | +$96.93K |
| 2026-08-10 | Rajeev A. Modi | SEE REMARKS | A | +66 deriv. | — |
| 2026-07-28 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +113 deriv. | — |
| 2026-07-28 | Rajeev A. Modi | SEE REMARKS | A | +59 deriv. | — |
| 2026-07-28 | Robert M VanHimbergen | EVP and CFO | A | +7 deriv. | — |
| 2026-07-14 | Robert M VanHimbergen | EVP and CFO | A | +7 deriv. | — |
| 2026-07-14 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +113 deriv. | — |
| 2026-07-14 | Rajeev A. Modi | SEE REMARKS | A | +59 deriv. | — |
| 2026-07-09 | Robert M VanHimbergen | EVP and CFO | F | −15,336 | −$377.88K |
| 2026-07-02 | David S Kinard | SEE REMARKS | A | +25,620 deriv. | — |
| 2026-07-02 | Kapila K Anand | Director | A | +584 deriv. | — |
| 2026-06-16 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +116 deriv. | — |
| 2026-06-16 | Robert M VanHimbergen | EVP and CFO | A | +8 deriv. | — |
| 2026-06-16 | Rajeev A. Modi | SEE REMARKS | A | +61 deriv. | — |
| 2026-06-02 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | A | +118 deriv. | — |
| 2026-06-02 | Rajeev A. Modi | SEE REMARKS | A | +61 deriv. | — |
| 2026-06-02 | Robert M VanHimbergen | EVP and CFO | A | +8 deriv. | — |
| 2026-05-26 | Art A Garcia | Director | A | +16,874 | — |
| 2026-05-26 | Stacey Ma | Director | A | +16,874 | — |
| 2026-05-26 | Kapila K Anand | Director | A | +16,874 | — |
| 2026-05-26 | Michael J Harrington | Director | A | +16,874 | — |
| 2026-05-26 | R David Hoover | Director | A | +4,678 | — |
| 2026-05-26 | Deborah Turner Kochevar | Director | A | +4,678 | — |
| 2026-05-26 | Paul Herendeen | Director | A | +16,874 | — |
| 2026-05-26 | Kirk P McDonald | Director | A | +16,874 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | 2,223,869 | $60.28M |
| Ramiro Martin Cabral | SEE REMARKS | 283,874 | $7.69M |
| Ellen de Brabander | SEE REMARKS | 280,821 | $7.61M |
| David S Kinard | SEE REMARKS | 214,264 | $5.81M |
| Todd S. Young | SEE REMARKS | 206,469 | $5.60M |
| Lawrence Erik Kurzius | Director | 188,647 | $5.11M |
| Rajeev A. Modi | SEE REMARKS | 160,812 | $4.36M |
| Timothy J Bettington | SEE REMARKS | 138,911 | $3.77M |
| Robert M VanHimbergen | EVP and CFO | 137,516 | $3.73M |
| Michael J Harrington | Director | 131,451 | $3.56M |
| R David Hoover | Director | 127,371 | $3.45M |
| John P Bilbrey | Director | 120,122 | $3.26M |
| Paul Herendeen | Director | 111,687 | $3.03M |
| Art A Garcia | Director | 108,152 | $2.93M |
| Denise Scots-Knight | Director | 105,588 | $2.86M |
| Grace McArdle | EVP, MANUFACTURING AND QUALITY | 103,705 | $2.81M |
| de Simas Jose Manuel Correia | SEE REMARKS | 101,017 | $2.74M |
| Kapila K Anand | Director | 99,651 | $2.70M |
| William F Doyle | Director | 94,499 | $2.56M |
| Deborah Turner Kochevar | Director | 94,392 | $2.56M |
| Kirk P McDonald | Director | 93,392 | $2.53M |
| Shiv O'Neill | GC AND CORP SEC | 87,832 | $2.38M |
| James M Meer | CHIEF ACCOUNTING OFFICER | 66,732 | $1.81M |
| Stacey Ma | Director | 29,727 | $805.75K |
| Kathy V Turner | Director | 13,838 | $375.08K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ELAN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.